Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis

Hum Genet. 1992 Jan;88(3):307-12. doi: 10.1007/BF00197265.

Abstract

Apolipoprotein E phenotypes and gene frequencies were determined in 560 patients receiving long-term hemodialysis. In addition, fasting plasma lipid- and apolipoprotein-concentrations were evaluated in 245 of these individuals. The distribution of the three major apolipoprotein E alleles (epsilon 4, epsilon 3, and epsilon 2) and that of the six common apolipoprotein E phenotypes (E4/4, E3/3, E2/2, E4/2, E4/3, and E3/2) in the dialysis group was nearly identical to that of healthy controls. Patients with the apolipoprotein E phenotypes E2/2, E4/4 and E4/3 (comprising 24% of the whole group) had higher mean plasma cholesterol- and triglyceride-concentrations than those with the apolipoprotein E phenotypes E3/3 and E3/2 (72% of the whole group). Thus, the genetic polymorphism of apolipoprotein E may contribute to the individual risk of accelerated atherosclerosis in patients under maintenance hemodialysis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Apolipoproteins E / blood
  • Apolipoproteins E / genetics*
  • Female
  • Humans
  • Hyperlipidemias / blood
  • Hyperlipidemias / genetics*
  • Kidney Failure, Chronic / therapy
  • Lipids / blood
  • Male
  • Middle Aged
  • Phenotype*
  • Polymorphism, Genetic
  • Renal Dialysis*

Substances

  • Apolipoproteins E
  • Lipids